scholarly journals Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Phunchai Charatcharoenwitthaya ◽  
◽  
Virasak Wongpaitoon ◽  
Piyawat Komolmit ◽  
Wattana Sukeepaisarnjaroen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Cohort Study ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Nonstructural Protein ◽  
Genotype 1 ◽  
Multicentre Cohort Study ◽  
Multicentre Cohort ◽  
Nonstructural Protein 5A

Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease

2018 ◽  
Vol 159 ◽  
pp. 143-152 ◽  
Author(s):  
Eiichi Ogawa ◽  
Norihiro Furusyo ◽  
Koichi Azuma ◽  
Makoto Nakamuta ◽  
Hideyuki Nomura ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Cohort Study ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Genotype 1

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

2019 ◽  
Vol 49 (6) ◽  
pp. 617-626 ◽  
Author(s):  
Eiichi Ogawa ◽  
Norihiro Furusyo ◽  
Makoto Nakamuta ◽  
Hideyuki Nomura ◽  
Takeaki Satoh ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Cohort Study ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Japanese Patients ◽  
Genotype 1

Real-world clinical practice and future prospects of interferon-free therapy in patients with chronic hepatitis C (genotype 1)

2018 ◽  
Vol 16 (2) ◽  
pp. 98-103 ◽  
Author(s):  
K.V. Zhdanov ◽  
◽  
K.V. Kozlov ◽  
V.S. Sukachev ◽  
S.S. Zhabrov ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Clinical Practice ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Future Prospects ◽  
Genotype 1
Sign in / Sign up

Export Citation Format

Share Document